Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-15-001716
Filing Date
2015-05-14
Accepted
2015-05-14 16:31:19
Documents
10
Period of Report
2015-04-04

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cdxc10q_apr42015.htm 10-Q 835610
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO ?240.13A?14 OR ?240.15D ex31-1.htm EX-31.1 8917
3 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO ?240.13A?14 OR ?240.15D ex31-2.htm EX-31.2 9016
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 (AS ADOPTED PURSUANT TO SECTION ex32-1.htm EX-32.1 4702
  Complete submission text file 0001415889-15-001716.txt   4190837

Data Files

Seq Description Document Type Size
5 cdxc-20150404.xml EX-101.INS 496201
6 cdxc-20150404.xsd EX-101.SCH 47014
7 cdxc-20150404_cal.xml EX-101.CAL 43929
8 cdxc-20150404_def.xml EX-101.DEF 79878
9 cdxc-20150404_lab.xml EX-101.LAB 270118
10 cdxc-20150404_pre.xml EX-101.PRE 207150
Mailing Address 10005 MUIRLANDS BLVD. STE. G, FIRST FLOOR IRVINE CA 92618
Business Address 10005 MUIRLANDS BLVD. STE. G, FIRST FLOOR IRVINE CA 92618 949-419-0288
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53290 | Film No.: 15863310
SIC: 2833 Medicinal Chemicals & Botanical Products